Divisions of Diagnostic Radiology, National Cancer Center Hospital, Japan; Department of Radiology, Kobe University, Graduate School of Medicine, Japan.
Eur J Radiol. 2013 Nov;82(11):e691-6. doi: 10.1016/j.ejrad.2013.07.003. Epub 2013 Aug 3.
To evaluate the efficacy and outcome of a flow confirmation study (FCS) in oncologic outpatients undergoing chemotherapy suspected of a central venous port (CVP) system-related mechanical complication.
A total of 66 patients (27 men, 39 women; mean age, 60 years) received FCS for the following reasons: prolonged infusion time during chemotherapy (n=32), inability to inject saline fluid (n=15), lateral neck and/or back pain (n=6), subcutaneous extravasation of anticancer drug (n=5), arm swelling (n=4), and inability to puncture the port (n=4). FCS consisted of examining the position of CVP, potential secondary shifts or fractures, and integrity of the system using contrast material through the port.
Of the 66 patients, 43 had an abnormal finding uncovered by FCS. The most frequent abnormal findings was catheter kinking (n=22). Explantation and reimplantation of the CVP system was required in 21 of the 66 patients. Remaining 45 patients were able continue using the CVP system after the FCS without any system malfunction.
FCS was effective for evaluating CVP system-related mechanical complications and was useful for deciding whether CVP system explantation and reimplantation was required.
评估在疑似中心静脉导管(CVP)系统相关机械并发症的肿瘤科门诊化疗患者中进行流量确认研究(FCS)的疗效和结果。
共有 66 名患者(男 27 例,女 39 例;平均年龄 60 岁)因以下原因接受 FCS:化疗期间输注时间延长(n=32)、无法注入生理盐水(n=15)、颈侧和/或背部疼痛(n=6)、抗癌药物皮下外渗(n=5)、手臂肿胀(n=4)和无法穿刺端口(n=4)。FCS 包括使用端口内的造影剂检查 CVP 的位置、潜在的继发性移位或骨折以及系统的完整性。
在 66 名患者中,有 43 名患者的 FCS 发现异常。最常见的异常发现是导管扭结(n=22)。在 66 名患者中,有 21 名需要对 CVP 系统进行取出和重新植入。其余 45 名患者在 FCS 后无需任何系统故障即可继续使用 CVP 系统。
FCS 可有效评估 CVP 系统相关的机械并发症,并有助于决定是否需要取出和重新植入 CVP 系统。